Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-860-3 | CAS number: 78182-00-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Valid acute toxicity data for the oral route of exposure are available for the test item DMAC Trocken Flüssig.
The test item was tested in Wistar rats according to the OECD TG 401 (1981) in BASFAG81/366 (1982).
For the males, the LD50 was > 5000 mg/kg bw
No data are available for the dermal and the inhalative route of exposure.
For the females, the LD50 was > 3160 — < 5000 mg/kg bw
Key value for chemical safety assessment
Additional information
Referring to the oral route, the test item first was tested at a dose level of 3160 mg/ kg bw in Wistar rats of both sexes according to the OECD TG 401 (1981); in this study, no mortalities occurred and therefore the LD50 for both sexes was set > 3160 mg/kg bw (BASFAG81/366[1981]). A further test was conducted under conditions similar as above; this time, the following dose levels were considered: 2150, 3160 and 5000 mg/kg bw (BASFAG81/366[1982]).
None of the male and female animals treated with 2150 and 3160 mg/kg bw died. At 5000 mg/kg bw, 2/5 males and 4/5 females died within 1 hour after treatment. Clinical symptoms only were seen in the high dose group, generally about 15 minutes to 4 hours after treatment. Males mainly suffered from dyspnoea, apathy, staggering, convulsion, diarrhea, and poor general state. Females mainly suffered from dyspnoea, apathy, abnormal position, staggering, convulsion, tremor, ruffled fur, diarrhea, cyanosis, breathlessness and poor general state. Body weights and body weight gain for the surviving animals of both sexes were inconspicuous. Necropsy of those animals that died revealed general congestive hyperemia and atonic intestines with diarrheic content. Necropsy of the animals that survived revealed no abnormalities.
Thus, the LD50 for both sexes was between 3160 and 5000 mg/kg bw.
Justification for classification or non-classification
For the oral route of exposure, a valid study revealed a LD50 for male and female rats that is > 3160 and < 5000 mg/kg bw.
According to the EU Directive 67/548/EC, no classification is needed.
According to the CLP Regulation 1271/2008, no classification is needed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.